Last reviewed · How we verify
Lingzhi and Sen Miao San
At a glance
| Generic name | Lingzhi and Sen Miao San |
|---|---|
| Also known as | Pingyin English name, Lingzhi Ganoderma lucidum seu Japonicum, Cangzhu Atractylodes lancea, Huangbo Phellodendron amurense, Niuxi Achyranthes bidentata B1 |
| Sponsor | Chinese University of Hong Kong |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lingzhi and Sen Miao San CI brief — competitive landscape report
- Lingzhi and Sen Miao San updates RSS · CI watch RSS
- Chinese University of Hong Kong portfolio CI